KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Return on Invested Capital (2021 - 2025)

Historic Return on Invested Capital for Castle Biosciences (CSTL) over the last 7 years, with Q3 2025 value amounting to 0.05%.

  • Castle Biosciences' Return on Invested Capital fell 500.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year decrease of 500.0%. This contributed to the annual value of 0.02% for FY2024, which is 1900.0% up from last year.
  • According to the latest figures from Q3 2025, Castle Biosciences' Return on Invested Capital is 0.05%, which was down 500.0% from 0.05% recorded in Q2 2025.
  • In the past 5 years, Castle Biosciences' Return on Invested Capital registered a high of 0.02% during Q4 2024, and its lowest value of 0.25% during Q2 2023.
  • For the 5-year period, Castle Biosciences' Return on Invested Capital averaged around 0.1%, with its median value being 0.08% (2021).
  • In the last 5 years, Castle Biosciences' Return on Invested Capital plummeted by -1500bps in 2023 and then soared by 2300bps in 2024.
  • Quarter analysis of 5 years shows Castle Biosciences' Return on Invested Capital stood at 0.08% in 2021, then tumbled by -130bps to 0.18% in 2022, then dropped by 0bps to 0.18% in 2023, then skyrocketed by 109bps to 0.02% in 2024, then crashed by -399bps to 0.05% in 2025.
  • Its Return on Invested Capital was 0.05% in Q3 2025, compared to 0.05% in Q2 2025 and 0.07% in Q1 2025.